- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging MEK inhibitors
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume 15, Issue 2, Pages 203-223
Publisher
Informa Healthcare
Online
2010-02-13
DOI
10.1517/14728210903282760
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer and aging: More puzzles, more promises?
- (2011) Mikhail V Blagosklonny et al. CELL CYCLE
- Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence
- (2011) Zoya N. Demidenko et al. CELL CYCLE
- Aging-suppressants: Cellular senescence (hyperactivation) and its pharmacologic deceleration
- (2011) Mikhail V Blagosklonny CELL CYCLE
- At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence
- (2011) Zoya N. Demidenko et al. CELL CYCLE
- Rapamycin decelerates cellular senescence
- (2011) Zoya N. Demidenko et al. CELL CYCLE
- Growth stimulation leads to cellular senescence when the cell cycle is blocked
- (2010) Zoya N. Demidenko et al. CELL CYCLE
- Aging: ROS or TOR
- (2010) Mikhail V Blagosklonny CELL CYCLE
- Integrating BRAF/MEK inhibitors into combination therapy for melanoma
- (2009) K S M Smalley et al. BRITISH JOURNAL OF CANCER
- Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
- (2009) Nathalie Dhomen et al. CANCER CELL
- Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression
- (2009) K. P. Hoeflich et al. CANCER RESEARCH
- Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
- (2009) O. K. Mirzoeva et al. CANCER RESEARCH
- In vitro and In vivo Radiosensitization with AZD6244 (ARRY-142886), an Inhibitor of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase 1/2 Kinase
- (2009) E. J. Chung et al. CLINICAL CANCER RESEARCH
- Emerging Raf inhibitors
- (2009) James A McCubrey et al. EXPERT OPINION ON EMERGING DRUGS
- BRAF Signaling and Targeted Therapies in Melanoma
- (2009) Nathalie Dhomen et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Trial Offers Early Test Case for Personalized Medicine
- (2009) K. Garber JNCI-Journal of the National Cancer Institute
- Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways
- (2008) P. Lunghi et al. BLOOD
- BRAF V600E Disrupts AZD6244-Induced Abrogation of Negative Feedback Pathways between Extracellular Signal-Regulated Kinase and Raf Proteins
- (2008) B. B. Friday et al. CANCER RESEARCH
- The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel
- (2008) N. K. Haass et al. CLINICAL CANCER RESEARCH
- Advances in the Development of Cancer Therapeutics Directed against the RAS-Mitogen-Activated Protein Kinase Pathway
- (2008) J. S. Sebolt-Leopold CLINICAL CANCER RESEARCH
- 577 POSTER Selective MEK Inhibitor RDEA119 exhibits efficacy in orthotopic hepatoma models and cytostatic potential in multiple cell based models of cancer
- (2008) J. Miner et al. EJC SUPPLEMENTS
- Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy
- (2008) J A McCubrey et al. LEUKEMIA
- Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance
- (2008) J A McCubrey et al. LEUKEMIA
- Targeting the leukemic stem cell: the Holy Grail of leukemia therapy
- (2008) N Misaghian et al. LEUKEMIA
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
- (2008) Jeffrey A Engelman et al. NATURE MEDICINE
- Aging, Stem Cells, and Mammalian Target of Rapamycin: A Prospect of Pharmacologic Rejuvenation of Aging Stem Cells
- (2008) Mikhail V. Blagosklonny REJUVENATION RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search